Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fertility-sparing treatment in advanced-stage serous borderline ovarian tumors. An analysis from the MITO14 study database.
Falcone F, Breda E, Ferrandina G, Malzoni M, Perrone AM, Cormio G, Di Donato V, Frigerio L, Mangili G, Raspagliesi F, Festi A, Scibilia G, Biglia N, Sorio R, Vizza E, Losito NS, Greggi S. Falcone F, et al. Among authors: losito ns. Gynecol Oncol. 2021 Jun;161(3):825-831. doi: 10.1016/j.ygyno.2021.03.023. Epub 2021 Mar 27. Gynecol Oncol. 2021. PMID: 33781554
Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22).
Musacchio L, Califano D, Bartoletti M, Arenare L, Lorusso D, Losito NS, Cormio G, Greggi S, Raspagliesi F, Valabrega G, Salutari V, Pisano C, Spina A, Russo D, Del Sesto M, Canzonieri V, Ferraù F, Zannoni GF, Loizzi V, Ghizzoni V, Casanova C, Tuninetti V, Ducceschi M, Del Vecchio V, Scalone S, Priolo D, Perrone F, Scambia G, Pignata S. Musacchio L, et al. Among authors: losito ns. Br J Cancer. 2022 Nov;127(8):1479-1486. doi: 10.1038/s41416-022-01897-1. Epub 2022 Jul 22. Br J Cancer. 2022. PMID: 35869143 Free PMC article.
Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional series.
Falcone F, Normanno N, Losito NS, Scognamiglio G, Esposito Abate R, Chicchinelli N, Casella G, Laurelli G, Scaffa C, Greggi S. Falcone F, et al. Among authors: losito ns. Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:220-225. doi: 10.1016/j.ejogrb.2019.07.013. Epub 2019 Jul 13. Eur J Obstet Gynecol Reprod Biol. 2019. PMID: 31326637
FEZ1/LZTS1 protein expression in ovarian cancer.
Califano D, Pignata S, Pisano C, Greggi S, Laurelli G, Losito NS, Ottaiano A, Gallipoli A, Pasquinelli R, De Simone V, Cirombella R, Fusco A, Chiappetta G. Califano D, et al. Among authors: losito ns. J Cell Physiol. 2010 Feb;222(2):382-6. doi: 10.1002/jcp.21962. J Cell Physiol. 2010. PMID: 19885841
New cell block containing agarose for cytopathological diagnosis of tumor samples.
Miceli R, Scognamiglio G, Camerlingo R, Rea G, Lettiero A, Cantile M, Greggi S, Losito NS, Pirozzi G, Botti G. Miceli R, et al. Among authors: losito ns. Diagn Cytopathol. 2017 Nov;45(11):1057-1060. doi: 10.1002/dc.23778. Epub 2017 Jun 30. Diagn Cytopathol. 2017. PMID: 28664554 No abstract available.
Lung cancer diagnosis on ovary mass: a case report.
Losito NS, Scaffa C, Cantile M, Botti G, Costanzo R, Manna A, Franco R, Greggi S. Losito NS, et al. J Ovarian Res. 2013 May 10;6(1):34. doi: 10.1186/1757-2215-6-34. J Ovarian Res. 2013. PMID: 23663245 Free PMC article.
Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion.
Minopoli M, Botti G, Gigantino V, Ragone C, Sarno S, Motti ML, Scognamiglio G, Greggi S, Scaffa C, Roca MS, Stoppelli MP, Ciliberto G, Losito NS, Carriero MV. Minopoli M, et al. Among authors: losito ns. J Exp Clin Cancer Res. 2019 Nov 8;38(1):459. doi: 10.1186/s13046-019-1465-8. J Exp Clin Cancer Res. 2019. PMID: 31703596 Free PMC article.
55 results